Orthofix Medical Inc.·4

Jan 9, 7:19 PM ET

Kenny Kevin J. 4

4 · Orthofix Medical Inc. · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2023-01-05
Kenny Kevin J
President of Global Spine
Transactions
  • Award

    Common Stock

    2023-01-05+12,229125,026 total
  • Award

    Common Stock

    2023-01-05+10,485112,797 total
  • Award

    Common Stock

    2023-01-05+20,492145,518 total
  • Award

    Common Stock

    2023-01-05+29,905102,312 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-01-05+72,14672,146 total
    Exercise: $20.90Exp: 2033-01-05Common Stock (72,146 underlying)
Footnotes (6)
  • [F1]The restricted stock units vest with respect to one-fourth (1/4th) of the shares of stock covered hereby on each of the first, second, third, and fourth anniversaries of the Grant Date.
  • [F2]Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.
  • [F3]Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.
  • [F4]Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.
  • [F5]Includes 124,049 unvested restricted stock units.
  • [F6]The option vests in four equal installments on each of January 5, 2023, January 5, 2024, January 5, 2025 and January 5, 2026.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT